Recombinant Anti-CD22 x Anti-saporin Bispecific Antibody (Tandem Diabody) (T-BSDB-053)

Recombinant Anti-CD22 x Anti-saporin Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can be used in pretargeting system and deliver immunotoxin to tumor cells. It is designed for the research of Lymphoma therapy.

Datasheet INQUIRY

Specifications

Targets

CD22 & saporin

Species Reactivity

Human

Application

FuncS Pretargeting system for immunotoxin delivery

Related Disease

Lymphoma

Targets

Target 1

CD22

Gene ID

933

UniProt ID

P20273

Alternative Names

CD22; CD22 molecule; Cluster of differentiation 22; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2

Target 2

saporin

Alternative Names

Saporin; Ribosome inactivating protein; RIP

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD22 x Anti-saporin Bispecific Antibody (Tandem Diabody) (T-BSDB-053). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD22 x Anti-saporin Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-053)

Specifications

Targets

Customer Reviews and Q&As